Nanjing Synthgene Medical Technology Co., Ltd. is a biomedical high-tech enterprise focusing on the research and development and production of in vitro diagnostic raw materials and POCT diagnostic reagents. The company has a mature technology platform, including protein expression and purification platform, hybridoma monoclonal antibody screening platform, antibody engineering design platform, etc., which provide a solid technical foundation for the development of diagnostic antibodies. At the same time, the company currently has a fluorescence chromatography platform and a latex turbidity platform. The company is committed to promoting accurate diagnosis of human diseases with high-quality diagnostic products and contributing to the cause of human health.